| LUAD | Lung adenocarcinoma |
| PTH2R | Parathyroid hormone 2 receptor |
| OS | Overall survival |
| SCLC | Small cell cancer |
| NSCLC | Non-small cell cancer |
| EGFR | Epidermal growth factor receptor |
| GPCRs | G protein-coupled receptors |
| VIPR1 | Vasoactive intestinal peptide receptors 1 and 2 |
| VIPR2 | Vasoactive intestinal peptide receptors 2 |
| PAC1R/ADCYAP1R1 | Pituitary adenylate cyclase-activating peptide receptor |
| SCTR | Secretin receptor |
| GHRHR | Growth hormone-releasing factor receptor |
| GCGR | Glucagon receptor |
| GLP1R | Glucagon-like peptide 1 receptor |
| GLP2R | Glucagon-like peptide 2 receptor |
| GIPR | Gastric inhibitory peptide receptor |
| PTH1R | Parathyroid hormone receptors 1 |
| CTR/CALCR | Calcitonin receptor |
| CALCRL | Calcitonin receptor-like receptor |
| CRF1R/CRHR1 | Corticotropin-releasing factor 1 receptor |
| CRF2R/CRHR2 | Corticotropin-releasing factor 2 receptor |
| TCGA | The Cancer Genome Atlas |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| GO | Gene Ontology |
| DAVID | Database for Annotation, Visualization and Integrated Discovery |
| ATCC | American Type Culture Collection |
| OD | Optical density |
| PBS | Phosphate buffer solution |
| IC50 | A half-maximal inhibition |
| DEGs | Differentially expressed genes |